Inceptua

Inceptua Group (Inceptua) is a provider of customized access solutions that enable pharmaceutical companies to overcome challenges and eliminate obstacles to reach patients with unmet medical needs and provide access to life-changing or life-extending therapies.  The group was founded in 1997, initially focused on sourcing comparator products and delivering services for clinical trials.  Later Inceptua was expanded in 2017 with the establishment of Inceptua Early Access, running early access programs worldwide.  Inceptua’s Early Access team combine regulatory and operational expertise with an ability to partner effectively with clients to confidently provide the guidance, recommendations and capabilities necessary to successfully plan for and execute global access programs.  Collectively, our experience covers 300+ early access programs, involving both free-of-charge and charged for products treating a variety of conditions, including many rare and orphan indications.  Our team leverage a wealth of expertise in managing the distribution of medicines to more than 120 countries around the world, including North America, the EU, LATAM, MENA, APAC regions and low/middle income countries across the globe.